$16.00
-0.06 (-0.37%)
Open$16.17
Previous Close$16.06
Day High$16.22
Day Low$15.87
52W High$17.57
52W Low$2.55
Volume—
Avg Volume54.5K
Market Cap84.80M
P/E Ratio—
EPS$-1.37
SectorBiotechnology
Analyst Ratings
Strong Sell
6 analysts
Price Target
-13.6% upside
Current
$16.00
$16.00
Target
$13.83
$13.83
$9.36
$13.83 avg
$17.78
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 809.2K | 116.64M | 118.58M |
| Net Income | -8,468,381 | -21,434,773 | -22,545,743 |
| Profit Margin | -1,046.4% | -18.4% | -19.0% |
| EBITDA | -31,925,817 | -23,823,087 | -23,688,809 |
| Free Cash Flow | — | -12,084,786 | -12,382,292 |
| Rev Growth | — | -8.2% | -9.4% |
| Debt/Equity | — | 0.42 | 0.48 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |